The global ultrasonic device market was valued at over $1.2 billion in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 2.7%, reaching over $1.425 billion by 2032.
This comprehensive report covers the global market for ultrasonic devices, including ultrasonic instruments and ultrasonic generators used in laparoscopic and related minimally invasive procedures.
The analysis includes unit sales, average selling prices (ASPs), market size, growth trends, market drivers and limiters, market forecasts through 2032, and historical data back to 2022. It also includes recent mergers and acquisitions, company profiles, product portfolios and leading competitors.
Growth in this market is supported by the clinical benefits of ultrasonic energy, including effective hemostasis, reduced smoke generation and minimal lateral thermal spread. Adoption in China and several Asia-Pacific markets also continues to create competitive pressure on direct energy devices.
Ultrasonic devices have been established in laparoscopic surgery since the 1990s. They are commonly used in procedures where controlled tissue dissection, visibility and reduced thermal spread are important. Their ability to combine multiple functions in one device makes them valuable across a range of surgical workflows.
The market is closely connected to broader minimally invasive surgery trends. As laparoscopic procedures remain widely performed across general surgery, gynecology and urology, ultrasonic devices continue to serve as a key energy modality alongside advanced bipolar and monopolar technologies.
Regional adoption patterns are important to market performance. In China and several other Asia-Pacific markets, ultrasonic devices continue to grow due to local manufacturing strength, surgeon familiarity and favorable cost positioning. In these markets, ultrasonic technology remains one of the main competitive pressures on direct energy devices.
Compared with monopolar electrosurgery and laser devices, ultrasonic instruments generate lower temperatures and avoid tissue charring. This can improve visibility within the operative field and support more controlled tissue handling. The lack of electrical current transmission also lowers the risk of unintended energy-related injury, which continues to support surgeon confidence.
Cost-effectiveness and modality selection also influence adoption. Hospitals evaluate ultrasonic devices alongside advanced bipolar and monopolar technologies based on procedural mix, surgeon preference and budget. Ultrasonic instruments offer multifunctionality by combining cutting, coagulation and dissection in one device, while reusable, disposable and reposable formats give hospitals different cost and workflow options.
Ultrasonic devices can cut and coagulate tissue at the same time, but they are not optimized for vessel sealing in the same way as advanced bipolar devices. This limits adoption in certain procedures where reliable vessel sealing is the main clinical priority. As a result, utilization is often strongest among surgeons familiar with both laparoscopic techniques and energy-based dissection.
Reprocessed devices also limit market growth. Budget constraints continue to support manufacturer-led and third-party reprocessing programs, especially because new ultrasonic instruments can be relatively expensive. Reprocessing reduces demand for new units and has a stronger effect in mature markets with established installed bases.
Ultrasonic generators provide the energy platform needed to power ultrasonic surgical instruments.
Each segment is analyzed through relevant quantitative measures, including market size, market shares, market forecasts, market growth rates, units sold and average selling prices.
Medtronic followed Ethicon as the second-leading competitor in the ultrasonic device market. The company’s market share has been rising as Sonicision™ gains traction, mostly at the expense of Olympus. Medtronic benefits from its broader laparoscopic and energy device presence, which allows it to compete across multiple minimally invasive surgery categories.
Olympus was the third-leading competitor in the market. Its SonoSurg™ product is not available in all markets, which limits its product exposure. The company also offers THUNDERBEAT™, which combines bipolar and ultrasonic energy in a reposable system. While Olympus aims to grow its advanced energy business unit, it continues to face strong competition from Ethicon and Medtronic.
Multifunctionality remains a key technology trend. Ultrasonic instruments can combine cutting, coagulation and dissection, reducing reliance on multiple tools during a procedure and helping improve workflow efficiency.
Reposable ultrasonic instruments are gaining relevance because they balance cost containment and operational efficiency. These devices can appeal to hospitals that want lower long-term costs without fully committing to reusable products.
Disposable ultrasonic devices remain important in settings where hospitals prioritize predictable performance, reduced reprocessing burden and infection control. Adoption depends on local budgets, hospital policies and procedure volume.
Reusable ultrasonic devices can provide long-term per-procedure cost advantages in high-volume centers. However, their use depends on reprocessing infrastructure, maintenance requirements and purchasing preferences.
Regional manufacturing and pricing trends are shaping competition, especially in China and other Asia-Pacific markets. Local manufacturers and cost-positioned ultrasonic systems can support adoption while increasing competitive pressure on both direct energy and premium ultrasonic platforms.
5 charts and 18 figures illustrating market segmentation and performance metrics.
Methodology Appendix and Acronym Glossary explaining data definitions and modeling assumptions.
Licensing options: single-user, site and enterprise.
This comprehensive report covers the global market for ultrasonic devices, including ultrasonic instruments and ultrasonic generators used in laparoscopic and related minimally invasive procedures.
The analysis includes unit sales, average selling prices (ASPs), market size, growth trends, market drivers and limiters, market forecasts through 2032, and historical data back to 2022. It also includes recent mergers and acquisitions, company profiles, product portfolios and leading competitors.
Growth in this market is supported by the clinical benefits of ultrasonic energy, including effective hemostasis, reduced smoke generation and minimal lateral thermal spread. Adoption in China and several Asia-Pacific markets also continues to create competitive pressure on direct energy devices.
Market Overview
The global ultrasonic device market includes ultrasonic instruments and ultrasonic generators used in laparoscopic and related minimally invasive procedures. These devices use ultrasonic energy to cut, coagulate and dissect tissue while limiting some of the risks associated with traditional electrosurgical methods.Ultrasonic devices have been established in laparoscopic surgery since the 1990s. They are commonly used in procedures where controlled tissue dissection, visibility and reduced thermal spread are important. Their ability to combine multiple functions in one device makes them valuable across a range of surgical workflows.
The market is closely connected to broader minimally invasive surgery trends. As laparoscopic procedures remain widely performed across general surgery, gynecology and urology, ultrasonic devices continue to serve as a key energy modality alongside advanced bipolar and monopolar technologies.
Regional adoption patterns are important to market performance. In China and several other Asia-Pacific markets, ultrasonic devices continue to grow due to local manufacturing strength, surgeon familiarity and favorable cost positioning. In these markets, ultrasonic technology remains one of the main competitive pressures on direct energy devices.
Market Drivers
Clinical benefits remain one of the main drivers of the global ultrasonic device market. Ultrasonic energy offers effective hemostasis during tissue dissection, minimal lateral thermal spread, reduced smoke generation and no electrical current passing through the patient’s body. These advantages support adoption in procedures where precision and safety are important.Compared with monopolar electrosurgery and laser devices, ultrasonic instruments generate lower temperatures and avoid tissue charring. This can improve visibility within the operative field and support more controlled tissue handling. The lack of electrical current transmission also lowers the risk of unintended energy-related injury, which continues to support surgeon confidence.
Cost-effectiveness and modality selection also influence adoption. Hospitals evaluate ultrasonic devices alongside advanced bipolar and monopolar technologies based on procedural mix, surgeon preference and budget. Ultrasonic instruments offer multifunctionality by combining cutting, coagulation and dissection in one device, while reusable, disposable and reposable formats give hospitals different cost and workflow options.
Market Limiters
The learning curve is an important limiter in the ultrasonic device market. Although ultrasonic instruments share some similarities with electrosurgical techniques, they have unique tissue effects and limitations. Surgeons need training and experience to use these devices effectively across different tissue types and procedure settings.Ultrasonic devices can cut and coagulate tissue at the same time, but they are not optimized for vessel sealing in the same way as advanced bipolar devices. This limits adoption in certain procedures where reliable vessel sealing is the main clinical priority. As a result, utilization is often strongest among surgeons familiar with both laparoscopic techniques and energy-based dissection.
Reprocessed devices also limit market growth. Budget constraints continue to support manufacturer-led and third-party reprocessing programs, especially because new ultrasonic instruments can be relatively expensive. Reprocessing reduces demand for new units and has a stronger effect in mature markets with established installed bases.
Market Coverage and Data Scope
- Quantitative coverage: Market size, market shares, market forecasts, market growth rates, units sold and average selling prices.
- Qualitative coverage: Market drivers and limiters, market size and growth trends, recent mergers and acquisitions, company profiles, product portfolios and leading competitors.
- Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
- Data types included: Unit sales, average selling prices, market size and growth trends, market drivers and limiters, market forecasts through 2032, historical data, recent mergers and acquisitions, company profiles and product portfolios.
- Method note: Market revenue is modeled using unit sales and average selling prices, with segmentation by device type used to assess demand across ultrasonic instruments and ultrasonic generators.
Markets Covered and Segmentation
Ultrasonic Device Market
- Device type: Ultrasonic instrument and ultrasonic generator.
Ultrasonic generators provide the energy platform needed to power ultrasonic surgical instruments.
Each segment is analyzed through relevant quantitative measures, including market size, market shares, market forecasts, market growth rates, units sold and average selling prices.
Competitive Analysis
Ethicon and its HARMONIC product line are positioned to lead the ultrasonic device market over the forecast period. The HARMONIC ACE® is widely considered the industry standard device and remains the most popular ultrasonic instrument. Ethicon’s long-standing position in ultrasonic energy supports strong brand recognition and continued surgeon familiarity.Medtronic followed Ethicon as the second-leading competitor in the ultrasonic device market. The company’s market share has been rising as Sonicision™ gains traction, mostly at the expense of Olympus. Medtronic benefits from its broader laparoscopic and energy device presence, which allows it to compete across multiple minimally invasive surgery categories.
Olympus was the third-leading competitor in the market. Its SonoSurg™ product is not available in all markets, which limits its product exposure. The company also offers THUNDERBEAT™, which combines bipolar and ultrasonic energy in a reposable system. While Olympus aims to grow its advanced energy business unit, it continues to face strong competition from Ethicon and Medtronic.
Technology and Practice Trends
Ultrasonic energy continues to be valued for reduced smoke generation and lower thermal spread compared with some traditional energy modalities. These features are especially important in procedures where visibility and tissue protection are priorities.Multifunctionality remains a key technology trend. Ultrasonic instruments can combine cutting, coagulation and dissection, reducing reliance on multiple tools during a procedure and helping improve workflow efficiency.
Reposable ultrasonic instruments are gaining relevance because they balance cost containment and operational efficiency. These devices can appeal to hospitals that want lower long-term costs without fully committing to reusable products.
Disposable ultrasonic devices remain important in settings where hospitals prioritize predictable performance, reduced reprocessing burden and infection control. Adoption depends on local budgets, hospital policies and procedure volume.
Reusable ultrasonic devices can provide long-term per-procedure cost advantages in high-volume centers. However, their use depends on reprocessing infrastructure, maintenance requirements and purchasing preferences.
Regional manufacturing and pricing trends are shaping competition, especially in China and other Asia-Pacific markets. Local manufacturers and cost-positioned ultrasonic systems can support adoption while increasing competitive pressure on both direct energy and premium ultrasonic platforms.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.Deliverables
51 pages of detailed narrative analysis, tables and figures.5 charts and 18 figures illustrating market segmentation and performance metrics.
Methodology Appendix and Acronym Glossary explaining data definitions and modeling assumptions.
Licensing options: single-user, site and enterprise.
Why This Report
- How large is the global ultrasonic device market, and how is it expected to grow through 2032?
- How are ultrasonic instruments and ultrasonic generators performing across global minimally invasive procedures?
- How are unit sales, average selling prices and market values changing over time?
- What clinical benefits support the continued adoption of ultrasonic energy?
- How do ultrasonic devices compare with monopolar, bipolar and laser-based alternatives?
- Why are China and other Asia-Pacific markets important to ultrasonic device growth?
- How do reprocessing programs affect new unit demand in mature markets?
- Which companies lead the ultrasonic device market, and how are Ethicon, Medtronic and Olympus positioned?
Table of Contents
Research Methodology
Ultrasonic Device Market
List of Charts
List of Figures
